Organon & Co. OGN
13.92 USD +0.02 (+0.14%)
Regular-session close
13.86 -0.06 -0.46%
After hours · Nov 18, 4:48 PM ET
13.88 Day range 13.92
5.69 52-week range 13.92
- YTD
- +94.14%
- 1 year
- +80.54%
Benzinga news
benzinga.com Reported Saturday, Organon Presents Real-World Data At ACR Showing 1.3% Switchback Rate After Over 16,000 US Veterans Switched From HUMIRA To HADLIMA Analysis of over 16,000 patients switched to HADLIMA® from HUMIRA® (adalimumab) showed a 1.3% switchback rate over a 12-month follow-up period1Data demonstrated the switching cohort had an average…
benzinga.com Organon To Present New Analysis Of Phase 3 Data Evaluating VTAMA Cream In Patients With Atopic Dermatitis, At 2026 ACAAI Annual Scientific Meeting New pooled post-hoc analysis of Phase 3 data evaluates consistency of VTAMA cream efficacy across diverse atopic dermatitis patient subgroupsOrganon (NYSE:OGN), a global healthcare company with a…
